Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies

Clinical trial NCT04594135 · UNKNOWN

Trial details

NCT number: NCT04594135
Sponsor: iCell Gene Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia T-cell Non-Hodgkin Lymphoma

Start date: 2020-12-01
Primary completion: 2023-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.